CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

• Evandro D. Bezerra,
• Terra L. Lasho,
• Christy M. Finke,
• Antoine N. Saliba,
• Michelle A. Elliott,
• Animesh D. Pardanani,
• Naseema Gangat,
• Abhishek A. Mangaonkar,
• Rhett P. Ketterling,
• Ayalew Tefferi,
• Eric Solary,
• Mrinal M. Patnaik

Affiliations

Evandro D. Bezerra

Division of Hematology, Mayo Clinic

Terra L. Lasho

Division of Hematology, Mayo Clinic

Christy M. Finke

Division of Hematology, Mayo Clinic

Antoine N. Saliba

Division of Hematology, Mayo Clinic

Michelle A. Elliott

Division of Hematology, Mayo Clinic

Animesh D. Pardanani

Division of Hematology, Mayo Clinic

Naseema Gangat

Division of Hematology, Mayo Clinic

Abhishek A. Mangaonkar

Division of Hematology, Mayo Clinic

Rhett P. Ketterling

Department of Laboratory Medicine and Pathology, Mayo Clinic

Ayalew Tefferi

Division of Hematology, Mayo Clinic

Eric Solary

Faculte de Medecine, Universite Paris-Saclay

Mrinal M. Patnaik

Division of Hematology, Mayo Clinic